2022-07-11


Congrats! Shanghai Huanghai Pharmaceutical Company was listed on the TOP100 proprietary Chinese medicine Enterprises in 2022

Recently, the third China Traditional Chinese Medicine Brand Building Conference released the 2022 annual 8 brands in the traditional Chinese medicine industry, and Shanghai Huanghai Pharmaceutical Company, a wholly-owned subsidiary of Shanghai Sundise Traditional Chinese Medicine Co., Ltd, was listed on the TOP100 proprietary Chinese medicine enterprises for the first time.

The 3rd China TCM Brand Building Conference was hosted by China Association of Traditional Chinese Medicine. On the basis of solicitation and research, after the preliminary review of the professional group and the final review of the comprehensive group, the brand of traditional Chinese medicine industry in 2022 was formed and announced at the conference. This conference released 8 brands, according to the types, they are divided into Chinese herbal materials, Chinese herbal medicine, Chinese patent medicine, inheritance and innovation, these four categories.

As a subsidiary manufacturer of Shanghai Sundise Traditional Chinese Medicine Co., Ltd, Shanghai Huanghai Pharmaceutical Company won the "TOP100 List of Chinese Patent Medicine Enterprises in 2022". It has reached the industry-leading level in the fields of independent research and development, production process and quality management of traditional Chinese medicine. It has won the honors of high-tech enterprises, Shanghai Quality benchmarking enterprises, Chinese medicine large varieties of science and technology competitiveness ranking enterprises, science and technology small giant (cultivation) enterprises, and Shanghai specialized and special new enterprises. Shanghai Huanghai Pharmaceutical Company has long inherited the essence in the field of traditional Chinese medicine. It adhered to the integrity and innovation, fully implemented the research and development, production, quality and management objectives, strived to write a new chapter of high-quality development.

 

As a modern Chinese medicine research and development and manufacturing platform, Shanghai Sundise Traditional Chinese Medicine Co., Ltd aims to inherit and carry forward Chinese medicine, takes Chinese medicine modernization, standardization and internationalization as the enterprise mission, and builds the whole industrial chain of modern Chinese medicine which based on the concept of evidence-based medicine with diagnosable diseases, controllable quality and verifiable effects. 

The company focuses on clinical refractory diseases and blank areas, gives full play to the advantages of traditional Chinese medicine, integrates industrial resources, catalyzes the collaborative innovation of production, research and medicine, and creates a modern, standardized and international well-known brand of traditional Chinese medicine.

The company ranked among the top 100 list of proprietary Chinese medicines, not only represents the recognition of the comprehensive strength of Shanghai Sundise Traditional Chinese Medicine Co., Ltd by the China Association of Traditional Chinese Medicine and the industry colleagues, but also greatly enhance the company's visibility and industry influence. It promotes the sustainable development of the company. Shanghai Sundise Traditional Chinese Medicine Co., Ltd will continue to invest in the research and development of traditional Chinese medicine, strengthen the brand building of traditional Chinese medicine, achieve brand value enhancement, and continue to contribute to the modernization of traditional Chinese medicine.